Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1177/1756283X16663882 http://scihub22266oqcxt.onion/10.1177/1756283X16663882 C5076773!5076773!27803743     free     free     free Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Therap+Adv+Gastroenterol 2016 ; 9 (6): 898-912 Nephropedia Template TP {{tp|p=27803743|t=2016. Hepatocellular adenoma: when and how to treat? Update of current evidence |pdf=|usr=}}{{27803743}} gab.com Text Hepatocellular adenoma: when and how to treat Update of current evidence JO: Therap Adv Gastroenterol http://www.kidney.de/pget.php?&tw=1&pmid=27803743 #FOAvip Hepatocellular adenoma (HCA) is a rare, benign liver tumor. Discovery of this tumor is usually as an incidental finding, correlated with the use of oral contraceptives, or pregnancy. Treatment options have focused on conservative management for the straightforward, smaller lesions (<5 cm), with resection preferred for larger lesions (>5 cm) that pose a greater risk of hemorrhage or malignant progression. In recent years, a new molecular subclassification of HCA has been proposed, associated with characteristic morphological features and loss or increased expression of immunohistochemical markers. This subclassification could possibly provide considerable benefits in terms of patient stratification, and the selection of treatment options. In this review we discuss the decision-making processes and associated risk analyses that should be made based on lesion size, and subtype. The usefulness of this subclassification system in terms of the procedures instigated as part of the diagnostic work-up of a suspected HCA will be outlined, and suitable treatment schemes proposed. Twit Text FOAVip Hepatocellular adenoma: when and how to treat Update of current evidence ????Therap Adv Gastroenterol http://www.kidney.de/pget.php?&tw=1&pmid=27803743 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=27803743 #FOAvip English Wikipedia <ref>{{Cite pmid|27803743}}</ref> Hepatocellular adenoma: when and how to treat? Update of current evidence #MMPMID27803743 Thomeer MG; Broker M; Verheij J; Doukas M; Terkivatan T; Bijdevaate D; De Man RA; Moelker A; IJzermans JN Therap Adv Gastroenterol 2016[Nov]; 9 (6): 898-912 PMID27803743show ga Hepatocellular adenoma (HCA) is a rare, benign liver tumor. Discovery of this tumor is usually as an incidental finding, correlated with the use of oral contraceptives, or pregnancy. Treatment options have focused on conservative management for the straightforward, smaller lesions (<5 cm), with resection preferred for larger lesions (>5 cm) that pose a greater risk of hemorrhage or malignant progression. In recent years, a new molecular subclassification of HCA has been proposed, associated with characteristic morphological features and loss or increased expression of immunohistochemical markers. This subclassification could possibly provide considerable benefits in terms of patient stratification, and the selection of treatment options. In this review we discuss the decision-making processes and associated risk analyses that should be made based on lesion size, and subtype. The usefulness of this subclassification system in terms of the procedures instigated as part of the diagnostic work-up of a suspected HCA will be outlined, and suitable treatment schemes proposed. äHepatocellular adenoma: when and how to treat? Update of current evide(epmc).pdf DeepDyve Pubget Overpricing